In this first installment of the Health Care Enforcement Quarterly Roundup for 2019, we continue to monitor trends we identified in 2018 and introduce new enforcement efforts that are expected to persist in the coming year. In this Roundup, we focus on increased enforcement activity against electronic health record (EHR) companies, enforcement against individuals (with an acute focus on the telemedicine industry), lower court interpretations of the landmark Escobar ruling, developments related to the Granston Memo and dismissal of False Claims Act (FCA) cases, potential changes to the FCA statute of limitations, and the current state of affairs in opioid litigations around the country. Click here to read the full issue of the Health Care Enforcement Quarterly Roundup. Click here to download a PDF of the issue.
This latest installment of the Health Care Enforcement Quarterly Roundup reflects on trends that persisted in 2018 and those emerging trends that will carry us into 2019 and beyond. Leading off with the US Department of Justice’s (DOJ) December announcement of its fiscal year 2018 False Claims Act (FCA) recoveries, it remains clear that the health care industry is a primary target of FCA enforcement activity. We also revisit the current state of implementation of DOJ’s Granston Memorandum, substantive revisions to the Yates Memorandum, critical interpretations of the landmark Escobar case (including those expected in the coming year), and continued enforcement activity in the pain management industry. Click here to read the full issue of the Health Care Enforcement Quarterly Roundup. Click here to download a PDF of the issue.
In the latest installment of Health Care Enforcement Quarterly Roundup, we examine key enforcement trends in the health care industry that we have observed over the past few months. In this issue, we report on: Practical applications of recent guidance from the US Department of Justice (DOJ) A recent blow to DOJ’s effort to use the federal False Claims Act (FCA) to attack Medicare Advantage reimbursement Continued enforcement efforts at the state and federal level to combat the opioid crisis Potential changes to the Stark Law and Anti-Kickback Statute Continued reporting on how the lower courts have interpreted the landmark Escobar case Click here to read the full issue of the Health Care Enforcement Quarterly Roundup. Join us on for a webinar discussion on Tuesday, October 23. will take a deep dive into the trends and issues covered in this installment of the Health Care Enforcement Quarterly Roundup. Click here to register.
How will key trends and developments in health care policy and enforcement impact future litigants? In the latest Health Care Enforcement Quarterly Roundup, we address this question in the context of: Continued interpretations of the landmark Escobar case The latest guidance from US Department of Justice (DOJ) leadership regarding enforcement priorities The uptick in state and federal efforts to combat the opioid crisis Recent court decisions regarding the use of statistical sampling in False Claims Act (FCA) cases A recent increase in regulatory scrutiny of co-location and shared services/equipment arrangements Materials from our corresponding Q2 webinar can be accessed below. Click here to read the full issue of the Health Care Enforcement Quarterly Roundup. Click here to view the archived webinar.
Health Care Enforcement Q2 Roundup Webinar Date: Tuesday, July 17, 2018 Time: 11:00 am PDT | 12:00 pm MDT | 1:00 pm CDT | 2:00 pm EDT REGISTER NOW How will recent developments and emerging trends related to health care fraud and abuse impact future investigation targets and litigants? Our upcoming Health Care Enforcement Quarterly Roundup webinar will address this critical question and discuss trends related to: Continued interpretations of landmark Escobar case Recent guidance from DOJ leadership regarding enforcement priorities Uptick in state and federal efforts to combat the opioid crisis Court guidance on the use of statistical sampling in False Claims Act (FCA) cases Growing Circuit split on key FCA provisions, including the public disclosure bar, statute of limitations and tolling of claims Other trends that are critical to health care business operations and compliance with the ever-changing regulatory landscape Attendees will also receive an advance...
The government’s focus on the US opioid crisis has been consistently expanding over the past year beyond manufacturers to reach prescribers and health care providers who submit claims to federal health care programs for opioid prescriptions. These efforts increasingly include investigations under the False Claims Act and administrative actions, in addition to the more traditional criminal approach to these issues. With the Trump administration's public health emergency orders, it is expected for the government's enforcement activities, including those instigated by relators and their counsel, to grow in this area. Continue Reading.